Profound Medical Corp. (PROF) Insider Trading Activity

NASDAQ$7.043+0.05 (0.72%)
Market Cap
$255.36M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
723 of 849
Rank in Industry
95 of 107

PROF Insider Trading Activity

PROF Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Profound Medical Corp.

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners …

Insider Activity of Profound Medical Corp.

Over the last 12 months, insiders at Profound Medical Corp. have bought $0 and sold $0 worth of Profound Medical Corp. stock.

On average, over the past 5 years, insiders at Profound Medical Corp. have bought $100,151 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 12,027 shares for transaction amount of $56,888 was made by Menawat Arun Swarup (CEO) on 2025‑05‑16.

List of Insider Buy and Sell Transactions, Profound Medical Corp.

2025-05-16PurchaseMenawat Arun SwarupCEO
12,027
0.0402%
$4.73
$56,888
+29.41%
2025-05-15PurchaseMenawat Arun SwarupCEO
10,003
0.0318%
$4.33
$43,263
+34.44%
2012-12-20SaleHOFER MICHAELdirector
40,000
0.0032%
$0.16
$6,400
2012-12-18PurchaseHOFER MICHAELdirector
40,000
0.0031%
$0.15
$6,200
2012-06-19PurchaseSchweitzer John H.Pres., CEO, Sec., Treas.
500,000
0.0003%
$0.00
$700
2012-06-19PurchaseTEJADA FREDdirector
500,000
0.0003%
$0.00
$700
2012-06-19PurchaseHOFER MICHAELdirector
500,000
0.0003%
$0.00
$700
2012-06-19PurchaseBLANCHET JUSTINChief Financial Officer
500,000
0.0003%
$0.00
$700
Total: 8

Insider Historical Profitability

31.92%
Schweitzer John H.Pres., CEO, Sec., Treas.
72500000
198.4529%
$506.77M10
Menawat Arun SwarupCEO
587089
1.607%
$4.1M20
+31.92%
BLANCHET JUSTINChief Financial Officer
500000
1.3686%
$3.5M10
TEJADA FREDdirector
500000
1.3686%
$3.5M10
HOFER MICHAELdirector
500000
1.3686%
$3.5M21

Historical Insider Profitability vs. Competitors

$9,837,727
35
7.68%
$94.71M
$1,105,104
34
-11.40%
$311.25M
$20,867,362
27
-3.90%
$467.11M
$58,749,198
24
16.21%
$100.45M
$842,771
15
6.44%
$214.28M

PROF Institutional Investors: Active Positions

Increased Positions43+113.16%4M+40.26%
Decreased Positions13-34.21%278,929-2.52%
New Positions25New3MNew
Sold Out Positions6Sold Out27,440Sold Out
Total Postitions68+78.95%15M+37.74%

PROF Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Fil Ltd$14,439.005.39%1.89M00%2025-09-30
Gagnon Securities Llc$13,275.004.95%1.73M-16,873-0.96%2025-09-30
Letko, Brosseau & Associates Inc$7,555.002.82%986,250-218,000-18.1%2025-09-30
Gagnon Advisors, Llc$6,869.002.56%896,67100%2025-09-30
Royce & Associates Lp$6,587.002.46%859,906+95,000+12.42%2025-09-30
Rosalind Advisors, Inc.$5,302.001.98%692,18500%2025-09-30
Timelo Investment Management Inc.$4,623.001.72%603,539-237,117-28.21%2025-09-30
Mmcap International Inc. Spc$3,837.001.43%500,859+10,000+2.04%2025-09-30
Royal Bank Of Canada$3,722.001.39%485,920+26,001+5.65%2025-09-30
Ring Mountain Capital, Llc$3,025.001.13%394,864+36,444+10.17%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.